Active	Status	Sponsor type	Region	Phase	Filter
6 Active 1 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Szabo, István
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants	Completed	2	373	Europe, Canada	REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis	Regeneron Pharmaceuticals	Venous Thromboembolism	05/24	05/24
kosashvili, yona
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants	Completed	2	373	Europe, Canada	REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis	Regeneron Pharmaceuticals	Venous Thromboembolism	05/24	05/24
Norman, Doron
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants	Completed	2	373	Europe, Canada	REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis	Regeneron Pharmaceuticals	Venous Thromboembolism	05/24	05/24
NCT03024008: Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II	Recruiting	1/2	20	RoW	BonoFill-II	BonusBio Group Ltd	Bone Fracture	06/22	09/22
Baurovskis, Aivars
ROXI-VTE II, NCT06454630: A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants	Completed	2	179	Europe	REGN7508, Enoxaparin, Inhixa	Regeneron Pharmaceuticals	Venous Thromboembolism	01/25	01/25
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants	Completed	2	373	Europe, Canada	REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis	Regeneron Pharmaceuticals	Venous Thromboembolism	05/24	05/24